Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

GH Research Ireland
$183.9m
June 2021

GH Research Ireland

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS IRELAND
atai Life Sciences
US$225m
June 2021

atai Life Sciences

Joint Bookrunner (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS IRELAND
View transaction detail
GH Research PLC
US$160m
June 2021

GH Research PLC

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS IRELAND US
View transaction detail
Blue Apron Holdings Inc.
June 2021

Blue Apron Holdings Inc.

Sole Bookrunner
EQUITY CAPITAL MARKETS TECHNOLOGY US
View transaction detail
Zeta Global
$215m
June 2021

Zeta Global

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US
Convey Holding Parent
$186.6m
June 2021

Convey Holding Parent

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Jamf
$322.5m
June 2021

Jamf

Co-Manager (Follow on)
EQUITY CAPITAL MARKETS TECHNOLOGY US
Hut 8
C$115m
June 2021

Hut 8

Sole Bookrunner (Bought/NASDAQ Listing)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
View transaction detail
Acuity
US$57.5m
June 2021

Acuity

Joint Bookrunner (US IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA US
View transaction detail
Enthusiast Gaming
US46m
June 2021

Enthusiast Gaming

Joint Bookrunner (Follow-on)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA US
View transaction detail
ATAI Life Sciences B.V.
$258m
June 2021

ATAI Life Sciences B.V.

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS UK
PLBY Group
$217m
June 2021

PLBY Group

Joint Bookrunner
EQUITY CAPITAL MARKETS TECHNOLOGY US
View transaction detail